Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)

Clinical trial NCT02280629 · COMPLETED

Trial details

NCT number: NCT02280629
Sponsor: Dr. Falk Pharma GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2014-10-01
Primary completion: 2018-10-05
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.